^ false
^ false
Vyant Bio. Stock Price Forecast. Should You Buy VYNT? ^ false Check if VYNT Stock has a Buy or Sell Evaluation. VYNT Stock Price (NASDAQ), Forecast, Predictions, Stock Analysis and Vyant Bio, Inc. News."> ^ false Check if VYNT Stock has a Buy or Sell Evaluation. VYNT Stock Price (NASDAQ), Forecast, Predictions, Stock Analysis and Vyant Bio, Inc. News."/>
GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
$0.194
+0 (+0%)
At Close: Mar 28, 2024
^ false {"nextTradingDay":"2024-04-23","open":"09:30","close":"15:59"}" >
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for Vyant Bio, Inc. Stock and on which exchange is it traded?
The symbol for Vyant Bio, Inc. is VYNT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Vyant Bio, Inc. Stock?
Vyant Bio, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Vyant Bio, Inc. Stock?
Vyant Bio, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Vyant Bio, Inc. Stock.

What's the current price of Vyant Bio, Inc. Stock?
As of the end of day on the Mar 28, 2024, the price of an Vyant Bio, Inc. (VYNT) share was $0.194.

What is the 52-week high and low for Vyant Bio, Inc. Stock?
The 52-week high for Vyant Bio, Inc. Stock is $0.720 and the 52-week low is $0.141.

What is the market capitalization of Vyant Bio, Inc. Stock?
As of the Mar 28, 2024, the market capitalization of Vyant Bio, Inc. is 1.228M.
Click to get the best stock tips daily for free!

About Vyant Bio, Inc.

Vyant Bio. Vyant Bio, Inc., a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule clinical candidates for rare CNS genetic disorders including Rett Syndrome (Rett), CDKL5 deficiency diso... VYNT Profile

^ false

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT